5.1 Encasement Without Compression

Malignant infiltration can encase the ureters, preventing both urine flow and ureteral dilation. The surrounding tumor mass creates a rigid environment that restricts collecting system expansion even as obstruction develops (1,8).

5.2 Acute Obstruction

Hydronephrosis requires time to develop. In acute complete obstruction, early imaging may precede visible dilation (1,3).

5.3 Volume Depletion

Patients with significant intravascular volume depletion produce less urine, limiting the distending pressure needed to cause hydronephrosis (1,5).

5.4 Reduced Baseline GFR

Patients with pre-existing CKD or severely reduced GFR from any cause produce less urine and are therefore less likely to develop detectable hydronephrosis (1,5).

6.1 Ultrasound Limitations and Pitfalls

Renal ultrasound remains the first-line imaging modality for evaluating AKI, but its limitations in detecting obstruction are well-documented:

Causes of false-negative ultrasound include: early acute obstruction, significant volume depletion reducing urine output, encasement by tumor or fibrosis preventing dilation, reduced baseline GFR limiting urine production, and operator or technical factors in bedside imaging (1,3,9).

6.2 Renal Resistive Index

Doppler ultrasound can provide functional information beyond anatomic assessment. The renal resistive index (RI) is calculated as (peak systolic velocity – end diastolic velocity) / peak systolic velocity.

The resistive index is influenced by age, vascular properties, systemic hemodynamics and intrinsic kidney disease. It may contribute to assessment but cannot independently establish or exclude obstruction (10,11,12,13).

Clinical Pearl: An elevated RI (>0.70) in the setting of clinical suspicion for obstruction but absent hydronephrosis should prompt further investigation. However, a normal RI does not exclude obstruction, and the test has significant limitations (10,11,12,13).

6.3 CT Secondary Signs

When hydronephrosis is absent, CT may demonstrate secondary signs of obstruction:

• Dense nephrogram: Increased parenchymal enhancement persisting into delayed phases
• Delayed pyelogram: Contrast excretion delayed relative to the contralateral kidney
• Perinephric stranding: Fat stranding around the kidney suggesting acute process
• Pyelosinus extravasation: Forniceal rupture from high collecting system pressure

The combination of dense nephrogram with delayed pyelogram was first described by Harrison et al. in 1979 as a marker of obstruction even when collecting system dilation is minimal (8).

⚠️ Warning: The combination of dense nephrogram with delayed pyelogram should raise suspicion for obstruction regardless of the appearance of the collecting systems (8).

7.1 Landmark Urology Publications

Spital et al., 1988: Four cases illustrated severe obstruction despite minimal or absent dilation on noninvasive imaging, with improvement after relief (2).

Kocurek et al., 1991: The review emphasizes possible obstruction without dilation in patients with pelvic malignancy (6).

Spital, 2020: An editorial highlights continuing underrecognition; it is not a diagnostic-accuracy study (7).

Harrison et al., 1979: A case of tumor-encased ureters illustrates a delayed pyelogram and dense nephrogram despite minimal dilation (8).

7.2 Literature Quality Analysis

The evidence base for NDOU consists primarily of case reports and small case series. The 2024 CKJ systematic review by Feliciangeli et al. represents the most comprehensive analysis to date, identifying only 49 patients across 23 publications over 44 years (1). Several limitations affect the literature:

• Publication bias: Cases are reported because they are unexpected; the true denominator of missed diagnoses is unknown
• Confirmation bias: Diagnosed cases require definitive testing; patients who never receive retrograde/antegrade pyelography cannot be counted
• Inconsistent definitions: Some studies define NDOU as “no hydronephrosis” while others include “minimal dilation”
• Heterogeneous populations: Case series mix malignancy, stones, and retroperitoneal fibrosis with different pathophysiology

Despite these limitations, the consistency of the phenomenon across decades, institutions, and etiologies supports the validity of NDOU as a clinical entity. The publication of case series in urology journals by urologists provides internal validation from the specialty most equipped to evaluate urinary tract obstruction.

7.3 Documented Urology Skepticism: Case Examples from the Literature

The literature contains explicit documentation of urology declining intervention despite clinical suspicion for NDOU:

Onuigbo et al. (2010): Three patients with severe AKI and absent or limited collecting-system dilation recovered kidney function after decompression. This small case series supports retaining obstruction in the differential despite reassuring imaging; it does not establish a universal intervention rule (14).

El-Alali et al. (2022): A case report described anuric AKI from malignant retroperitoneal fibrosis as a presentation of metastatic breast cancer, with little initial evidence of obstruction on renal imaging (15).

Clinical coordination: Discuss persistent concern promptly with urology and interventional radiology. Select further imaging or decompression collaboratively, considering severity, likely obstruction site, infection and procedural risk (14).

7.4 Understanding Urology Skepticism

Urology skepticism is understandable from a training perspective. Urologists are surgical specialists whose entire approach to obstruction is predicated on identifying a problem amenable to procedural intervention. Hydronephrosis serves as the “target” that justifies intervention. When that target is absent, the indication for invasive procedures becomes less clear.

Furthermore, retrograde pyelography and cystoscopy are not without risk: anesthesia, instrumentation trauma, infection, and ureteral perforation are all potential complications. Proceeding to these procedures without imaging evidence of obstruction requires confidence in clinical judgment over objective findings—a difficult position for any specialist.

The solution is not to criticize urology colleagues but to provide them with the clinical context and literature support needed to make an informed decision. Citing the urology literature directly demonstrates that the request is grounded in evidence from their own specialty.

When obstruction remains plausible despite absent hydronephrosis, communicate the risk factors, AKI course, prior imaging, and reason for concern to urology. Nondilated obstruction is described in the literature, particularly in selected high-risk settings; a negative ultrasound is not an absolute exclusion. The need for further imaging or invasive evaluation should be determined with the treating specialists rather than from a universal prevalence estimate.

8.1 Clinical Scenario

The typical patient is an elderly male with known BPH, progressive urinary symptoms, and presentation with AKI. Ultrasound demonstrates a markedly distended bladder (PVR > 500 mL or even > 1 L) but no hydronephrosis. Catheter placement drains large volumes of urine. The question arises: will renal function improve with drainage alone, or has chronic obstruction already caused irreversible injury?

8.2 Evidence Base: Limited but Supportive

Recovery after decompression depends on obstruction duration/severity, infection and pre-existing kidney disease. The prospective study by Khalaf et al. concerns unilateral obstruction with a normal opposite kidney; it should not be treated as a TURP or nondilated chronic-retention trial (17). Following relief, monitor urine output, fluid balance and electrolytes because post-obstructive diuresis can cause clinically important losses (4).

8.3 The Evidence Gap

The specific question—does renal function improve in patients with chronic retention, high PVR, AKI, and NO hydronephrosis—has not been directly addressed in prospective studies. The available evidence is largely clinical observation:

• Clinicians report improvement in creatinine after catheterization in this population, but published series specifically isolating these patients are lacking
• The pathophysiology would suggest that if the AKI is due to bladder-level obstruction impairing renal function (even without visible upper tract dilation), relief should improve function
• The absence of hydronephrosis may indicate a compliant upper tract that decompresses into the distended bladder, but this does not preclude functional obstruction

In summary, the improvement observed in these patients is supported by physiologic reasoning and clinical experience but lacks the high-quality evidence of prospective trials. Most nephrologists and urologists would agree that a trial of catheter drainage is low-risk and reasonable, but the predictive factors for recovery are not well-defined.

Clinical Pearl: In patients with chronic retention, high PVR, and AKI without hydronephrosis, a trial of bladder drainage is reasonable. Post-obstructive diuresis after catheterization requires monitoring and is not a guarantee of complete kidney recovery. However, the evidence base for this specific population is limited to clinical observation rather than prospective data (4,16,17).

9.1 Diagnostic Approach

When NDOU is suspected, the following approach is recommended:

• Assess for high-risk features: pelvic malignancy, recent stone passage, retroperitoneal process, severe unexplained oliguria/anuria
• Review imaging critically for secondary signs: perinephric stranding, dense nephrogram, delayed pyelogram, asymmetric enhancement
• Consider Doppler RI if available, recognizing its limitations
• If clinical suspicion remains high despite negative imaging, proceed to definitive testing

9.2 Definitive Testing

Options for definitive evaluation include:

• Retrograde pyelography: Performed by urology, allows direct visualization and potential intervention
• Antegrade pyelography: Performed by interventional radiology, can be combined with nephrostomy placement
• Empiric nephrostomy: In critically ill patients with high suspicion, therapeutic trial of drainage may be diagnostic

9.3 Communication Strategy

Effective interdisciplinary communication is essential. When consulting urology or IR, provide:

• Specific high-risk features present in this patient
• Summary of current renal function and trajectory
• Explicit citation of the urology literature supporting NDOU
• Clear statement of the requested intervention

⚠️ Warning: Missing the diagnosis of NDOU converts a potentially reversible cause of AKI into permanent kidney failure. When clinical suspicion is high, advocate persistently for definitive testing (4,5,14,15).